China is a major producer of active pharmaceutical ingredients, with a production volume of 1.36 million tons in 2012, a year-on-year increase of 9.05%, ranking first in the world. The achievement of economies of scale benefits from the low cost of production and environmental pollution in China. In the current situation where prices are generally rising and environmental management is constantly strengthening, the cost advantage of industry development has become less obvious.
Internationally, China's biggest competitor, India, although not as large in industry development as China, has significant advantages in cost advantage and industry development speed compared to China.
The domestic and international environment for the development of active pharmaceutical ingredients
Feb 05, 2024







